- 1. Ashina S., Bendtsen L., Burstein R. et al. (2022) Pain sensitivity in relation to frequency of migraine and tension-type headache with or without coexistent neck pain: an exploratory secondary analysis of the population study. Scand. J. Pain, 23(1): 76–87. doi: 10.1515/sjpain-2022-0030.
- 2. Букреєва Ю.В., Кальбус О.І. (2024) Хронічний головний біль. Хронічна мігрень з щоденним головним болем (огляд літератури). Укр. мед. часопис, 4(162): umj.com.ua/uk/publikatsia-252564-hronichnij-golovnij-bil-hronichna-migren-z-shhodennim-golovnim-bolem-oglyad-literaturi.
- 3. Gaul C., Meßlinger K., Holle-Lee D., Neeb L. (2017) Pathophysiology of Headaches. Dtsch Med Wochenschr., 142(6): 402–408. doi: 10.1055/s-0042-111694.
- 4. Guven Kose S., Kose H.C., Celikel F. et al. (2022) Chronic Pain: An Update of Clinical Practices and Advances in Chronic Pain Management. Eurasian J. Med., 54(Suppl. 1): 57–61. doi: 10.5152/eurasianjmed.2022.22307.
- 5. Melzack R. (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain, 1(3): 277–299. doi: 10.1016/0304-3959(75)90044-5.
- 6. Vahedi M., Mazdeh M., Hajilooi M. et al. (2018) The Relationship Between Salivary Alpha Amylase Activity and Score of McGill Pain Questionnaire in Patients With Tension Type Headache. Basic Clin. Neurosci., 9(1): 59–64. doi: 10.29252/nirp.bcn.9.1.59.
- 7. Mongini F., Deregibus A., Raviola F., Mongini T. (2003) Confirmation of the distinction between chronic migraine and chronic tension-type headache by the McGill Pain Questionnaire. Headache, 43(8): 867–877. doi.org/10.1 046/j.1526-4610.2003.03165.x.
- 8. Elizagaray-García I., Carvalho G.F., Szikszay T.M. et al. (2022) Psychophysical testing in chronic migraine and chronic tension type headache: An observational study. Cephalalgia, 42(7): 618–630. doi: 10.1177/03331024211060315.
- 9. Auvray M., Myin E., Spence C. (2010) The sensory-discriminative and affective-motivational aspects of pain. Neurosci. Biobehav. Rev., 34(2): 214–223. doi: 10.1016/j.neubiorev.2008.07.008.
- 10. Kaniecki R.G., Friedman D.I., Asher D. et al. (2023) Improving to Four or Fewer Monthly Headache Days Per Month Provides a Clinically Meaningful Therapeutic Target for Patients with Chronic Migraine. Pain Ther., 12(5): 1179–1194. doi: 10.1007/s40122-023-00525-x.
- 11. Altamura C., Brunelli N., Viticchi G. et al. (2023) Quantitative and Qualitative Pain Evaluation in Response to OnabotulinumtoxinA for Chronic Migraine: An Observational Real-Life Study. Toxins (Basel), 15(4): 284. doi: 10.3390/toxins15040284.
|